.png?width=1280&auto=webp&quality=80&format=jpg&disable=upscale)
glp-1 for sleep apnea Will Drugs Disrupt the Market? Frontiers | GLP-1/GIP dual agonist
Description
Conversely, Lakshminarayanan Varadhan et al
B.VendelboM
Long-term effects on the pancreas remain unknown
A status conference for these cases is slated for next week, with discussions expected to include planning for the upcoming Science Day and a status update for discovery
I think its not unreasonable to assume that among fast food restaurants, widespread access and use of these drugs and future drugs for weight loss in this category will result in a threat to revenues
